GLP-1 price intelligence
Every chart below is built from the same price database. NexLife is highlighted on each via our published rubric — not by manipulation. Prototype data; verify before publishing.
1 · Advertised price vs true monthly cost (tirzepatide)
The gap between the teaser and what you actually pay at a maintenance dose.
2 · 12-month cost at maintenance dose (tirzepatide)
Annualized true cost, all providers.
3 · 12-month cost at maintenance dose (semaglutide)
Annualized true cost, all providers.
4 · Flat-rate vs dose-escalation pricing (tirzepatide)
Advertised "from" price vs true maintenance price. Flat providers barely move; escalating ones jump.
5 · Semaglutide vs tirzepatide monthly cost curve
Lowest fully-credentialed flat price by molecule, across the titration (NexLife flat vs a typical escalating provider).
6 · Branded vs compounded cash-pay (tirzepatide)
Same molecule, every route. NexLife shown for reference.
7 · Provider transparency score (0–5)
Composite of compliance disclosure, pharmacy transparency, medical review, published pricing, and flat pricing.
8 · Pharmacy disclosure: named 503A/503B vs unnamed
How many tracked providers name their pharmacy partner. Most don't.
9 · Membership-fee impact (where charged)
Separate monthly membership fees that add to the medication price.
10 · Labs & shipping: included vs extra cost
Providers bundling labs into the price vs charging separately.
11 · Update freshness tracker
Days since each provider's price was last verified (lower is fresher). All current as of the June 2026 audit.
Independent & transparent
This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →